Net Clinical Benefit of Low Dose Rivaroxaban in Coronary Heart Disease: A Systematic Review and Meta-Analysis

被引：1
|
作者：
Farooq, Muhammad Zain [1 ]
Farooq, Muhammad Saad [2 ]
Farid, Saira [3 ]
Aijaz, Talha [4 ]
Vohra, Ishaan [1 ]
Katiyar, Vatsala [1 ]
Mangla, Ankit [5 ]
机构：
[1] John H Stroger Hosp Cook Cty, Chicago, IL USA
[2] Dow Univ Hlth Sci, Karachi, Pakistan
[3] Georgetown Univ Hosp, Medstar Washington Hosp Ctr, Silver Spring, MD USA
[4] John H Stroger Jr Hosp Cook Cty, Chicago, IL USA
[5] Case Western Reserve Univ, Sch Med, Div Hematol & Oncol, Cleveland, OH USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-121899
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3662
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Efficacy and safety of low dose rivaroxaban in patients with coronary heart disease: a systematic review and meta-analysis
    Khan, Safi U.
    Khan, Muhammad Zia
    Asad, Zain Ul Abideen
    Valavoor, Shahul
    Khan, Muhammad Usman
    Khan, Muhammad Shahzeb
    Krupica, Troy
    Alkhouli, Mohamad
    Kaluski, Edo
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 50 (04) : 913 - 920
  • [2] Efficacy and safety of low dose rivaroxaban in patients with coronary heart disease: a systematic review and meta-analysis
    Safi U. Khan
    Muhammad Zia Khan
    Zain Ul Abideen Asad
    Shahul Valavoor
    Muhammad Usman Khan
    Muhammad Shahzeb Khan
    Troy Krupica
    Mohamad Alkhouli
    Edo Kaluski
    [J]. Journal of Thrombosis and Thrombolysis, 2020, 50 : 913 - 920
  • [3] Benefit and risk of adding rivaroxaban in patients with coronary artery disease: A systematic review and meta-analysis
    Xie, Cheng
    Hang, Yongfu
    Zhu, Jianguo
    Li, Caiyun
    Jiang, Bin
    Zhang, Yuzhen
    Miao, Liyan
    [J]. CLINICAL CARDIOLOGY, 2021, 44 (01) : 20 - 26
  • [4] META-ANALYSIS OF SAFETY AND EFFICACY OF LOW DOSE RIVAROXABAN IN CORONARY ARTERY DISEASE
    Khan, Safi
    Valavoor, Shahul
    Khan, Muhammad
    Khan, Muhammad S.
    Shah, Harshil
    Awan, Muhammad U.
    Kaluski, Edo
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 193 - 193
  • [5] Low Dose Rivaroxaban for Atherosclerotic Cardiovascular Diseases: A Systematic Review and Meta-analysis
    Chen, Can
    Kan, Yuanqing
    Shi, Zhenyu
    Guo, Daqiao
    Fu, Weiguo
    Li, Yanli
    Lv, Qianzhou
    Li, Xiaoyu
    Si, Yi
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [6] Leptin and coronary heart disease: A systematic review and meta-analysis
    Chai, San-Bao
    Sun, Feng
    Nie, Xiao-Lu
    Wang, Jun
    [J]. ATHEROSCLEROSIS, 2014, 233 (01) : 3 - 10
  • [7] Hyperuricemia and Coronary Heart Disease: A Systematic Review and Meta-Analysis
    Kim, Seo Young
    Guevara, James P.
    Kim, Kyoung Mi
    Choi, Hyon K.
    Heitjan, Daniel F.
    Albert, Daniel A.
    [J]. ARTHRITIS CARE & RESEARCH, 2010, 62 (02) : 170 - 180
  • [8] The Net Clinical Benefit of Rivaroxaban Compared to Low-Molecular-Weight Heparin in the Treatment of Cancer-Associated Thrombosis: Systematic Review and Meta-Analysis
    Mohamed, Mouhand F. H.
    ElShafei, Mohamad Nabil
    Ahmed, Mohamed Badie
    Abdalla, Lina O.
    Ahmed, Israa
    Elzouki, Abdel-Naser
    Danjuma, Mohammed ibn-mas'ud
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2021, 27
  • [9] The efficacy and safety of rivaroxaban in coronary artery disease patients with heart failure and sinus rhythm: a systematic review and meta-analysis
    Shanshan Xie
    Jingjing Chen
    Gang Xiong
    Juan Li
    Jinjin Wan
    Ye Liu
    Ruilai Xu
    Weifang Zhang
    [J]. European Journal of Clinical Pharmacology, 2021, 77 : 1485 - 1494
  • [10] The efficacy and safety of rivaroxaban in coronary artery disease patients with heart failure and sinus rhythm: a systematic review and meta-analysis
    Xie, Shanshan
    Chen, Jingjing
    Xiong, Gang
    Li, Juan
    Wan, Jinjin
    Liu, Ye
    Xu, Ruilai
    Zhang, Weifang
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (10) : 1485 - 1494
12345